Your Account
close button

Use our patient tools for secure, convenient, 24/7 access. Learn more

OR

This facility is a member of


Connect with us:

Lymphoma Cancer

   


A Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System (CNS) Lymphoma [ECOG 1F05]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.

A Three-Arm Randomized Phase II Trail of Bendamustine-Rituximab (BR) Followed by Rituximab vs. Bortezomib- BR (BVR) Followed by Rituximab vs. BR followed by Lenalidomide/Rituximab in High-Risk Follicular Lymphoma [ECOG 2408]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.

 

Share